Certolizumab pegol Withdrawn Phase 3 Trials for Crohn's Disease (CD) Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00354367Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining Fistulas
NCT00358683A Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol in Crohn's Disease